| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.0M | +1057.1% |
| Cost of Revenue | $500K | -14.1% |
| Gross Profit | $5.5M | +8998.4% |
| R&D Expense | $3.5M | -4.0% |
| SG&A Expense | $23.1M | +128.6% |
| Operating Income | -$243.8M | -1653.9% |
| Pre-tax Income | -$40.9M | -248.2% |
| Income Tax | $0 | — |
| Net Income | -$40.9M | -248.2% |
| EPS (Basic) | -$1.85 | +57.3% |
| EPS (Diluted) | -$1.85 | +57.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.3M | +569.3% |
| Inventory | $1.1M | +8.2% |
| Current Assets | $31.2M | +809.9% |
| Total Assets | $303.9M | +8480.7% |
| Current Liabilities | $3.0M | +39.4% |
| Total Liabilities | $3.0M | +21.5% |
| Stockholders' Equity | $300.9M | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.5M | -49.6% |
| Capital Expenditures | $5K | +0.0% |
| Investing Cash Flow | -$426.5M | — |
| Financing Cash Flow | $449.2M | +6360.2% |
| Free Cash Flow | -$16.5M | -49.5% |